Stock EYEN EYENOVIA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Eyenovia, Inc.

Equities

EYEN

US30234E1047

Market Closed - Nasdaq
Other stock markets
 21:00:00 30/04/2024 BST 		5-day change 1st Jan Change
0.751 USD +5.45% Intraday chart for Eyenovia, Inc. +38.41% -63.89%
04-25 Eyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi and Clobetasol Propionate Ophthalmic Suspension CI
04-08 Eyenovia to Weigh Potential Sale, Other Strategic Alternatives MT

Evolution of the average Target Price on Eyenovia, Inc.

Price target over the last 5 years

History of analyst recommendation changes

71c5d7e.xgE70c3IgPtWBRCe3ybSFuKjJhhHaLt2tNhTVXmTBbs.9DlRnJX4ypIiTiHn6WO5ZLHNEn4sH-wb3rUJHQzacdDzVn6G9Lq0gT5sWQ~76c12547a74b582e362f402e1a1a2932

Analyst Recommendations on Eyenovia, Inc.

William Blair Initiates Eyenovia at Outperform Rating MT
HC Wainwright Starts Eyenovia at Buy With $12 Price Target MT
Northland Adjusts Eyenovia's Price Target to $9 From $12, Maintains Outperform Rating MT
EYENOVIA : HC Wainwright Adjusts Price Target on Eyenovia to $8 From $6, Maintains Buy Rating MT
EYENOVIA : Northland Starts Eyenovia at Outperform With $10 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
0.751 USD
Average target price
9.333 USD
Spread / Average Target
+1,142.79%
High Price Target
12 USD
Spread / Highest target
+1,497.87%
Low Price Target
6 USD
Spread / Lowest Target
+698.93%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Eyenovia, Inc.

William Blair & Co.
HC Wainwright
Northland Securities

Ratings for Eyenovia, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. EYEN Stock
  4. Consensus Eyenovia, Inc.